USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Valorisation HSJ, Limited Partnership

USPTO PatentsView assignee record - 10 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

17.3

Avg claims per patent

-33%

5-year filing velocity

The verdict

Valorisation holds 10 US patents across 18 technology areas, rank #27,736 of 50,000 tracked assignees.

#27,736
of 50,000 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 17.3
avg claims per patent: -33%
filing velocity, last 5 yrs

Portfolio overview

Valorisation HSJ, Limited Partnership has been granted 10 US utility patents between 2015 and 2025, placing Valorisation HSJ, Limited Partnership at rank #27,736 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Valorisation HSJ, Limited Partnership is one of the more focused assignees in the PatentsView dataset. By volume, Valorisation sits between Uwiz Technology Co., Ltd. (10 patents, rank #27,732) and Verisilicon Microelectronics (nanjing) Co., Ltd. (10 patents, rank #27,740) - the closest US assignees by grant volume. The composite Innovation Score of 40.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 6 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Valorisation HSJ, Limited Partnership's 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Valorisation HSJ, Limited Partnership against peers pursuing similar technology classes.

Uwiz Technology

10
Vallourec Drillin…

10
Vallourec Tubes F…

10
Valneva

10
VEDA Data Solutio…

10
VELO Enterprise

10
Venus Aerospace

10
Verisilicon Micro…

10
Valorisation HSJ… ◀

10

What this shows Valorisation holds 10 patents at rank #27,736, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Valorisation

By rank, the assignees closest to #27,736 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Valorisation's primary technology class.

Valorisation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Valorisation HSJ, Limited Partnership patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	1	10.0%
2017	2	20.0%
2018	1	10.0%
2019	1	10.0%
2021	1	10.0%
2022	1	10.0%
2023	1	10.0%
2025	1	10.0%

Which technologies does Valorisation HSJ, Limited Partnership patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 5

C07K - PEPTIDES 5

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 5

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4

C10M - LUBRICATING COMPOSITIONS ; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION 2

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 2

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 2

C08B - POLYSACCHARIDES; DERIVATIVES THEREOF 2

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 2

C10N - INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS 2

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

C07D - HETEROCYCLIC COMPOUNDS 1

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#27,736

Across all tracked assignees

Innovation Score

40.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Valorisation HSJ, Limited Partnership hold?

Valorisation HSJ, Limited Partnership holds 10 US granted patents filed between 2015 and 2025, spanning 18 technology areas.

What is Valorisation HSJ, Limited Partnership's Innovation Score?

Valorisation HSJ, Limited Partnership has an Innovation Score of 40.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Valorisation HSJ, Limited Partnership focus on?

Valorisation HSJ, Limited Partnership's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 5 patents. The company has filed patents in 18 CPC subclasses total.

Is Valorisation HSJ, Limited Partnership's patent filing rate increasing or decreasing?

Valorisation HSJ, Limited Partnership's recent filing velocity is -33% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Valorisation HSJ, Limited Partnership's patents?

Valorisation HSJ, Limited Partnership's patents average 17.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Valorisation HSJ, Limited Partnership patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Valorisation's 10 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Valorisation ranks #27,736 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.